Geographic Access Disparities to Clinical Trials in Diabetic Eye Disease in the United States.
Adolescent
Adult
Aged
Child
Child, Preschool
Clinical Trials as Topic
/ organization & administration
Cross-Sectional Studies
Diabetic Retinopathy
/ epidemiology
Disease Management
Female
Health Services Accessibility
/ organization & administration
Healthcare Disparities
/ organization & administration
Humans
Infant
Infant, Newborn
Male
Middle Aged
Morbidity
/ trends
Retrospective Studies
United States
/ epidemiology
Young Adult
Diabetic eye disease
Diabetic retinopathy
Geographic accessibility
Journal
Ophthalmology. Retina
ISSN: 2468-6530
Titre abrégé: Ophthalmol Retina
Pays: United States
ID NLM: 101695048
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
26
10
2020
revised:
09
12
2020
accepted:
10
12
2020
pubmed:
20
12
2020
medline:
1
2
2022
entrez:
19
12
2020
Statut:
ppublish
Résumé
To identify geographic and socioeconomic variables predictive of residential proximity to diabetic eye disease clinical trial locations. Cross-sectional, retrospective study. De-identified census tract-level data from public datasets and trial-level data from ClinicalTrials.gov. Using public data from ClinicalTrials.gov, we identified all active interventional clinical trials in diabetic eye disease since 2017. After geolocating every trial site, we used an origin-destination cost-matrix to calculate the driving distance and travel time from the population-weighted United States census tract centroid to the nearest site. We then used public databases to identify census tract-level socioeconomic factors predictive of driving distance and time. Driving distance > 60 miles and time traveled > 60 minutes to the nearest clinical trial site. In a multivariate model, driving distance of more than 60 miles had a significant association with rural versus urban location (adjusted odds ratio, 5.22; 95% confidence interval [CI], 3.75-7.26; P < 0.001), percentage of population at less than 200% of federal poverty level compared with the fourth quartile (first quartile: adjusted odds ratio, 0.40 [95% CI, 0.29-0.55]; second quartile: adjusted odds ratio, 0.60 [95% CI, 0.47-0.77]; third quartile: adjusted odds ratio, 0.76 [95% CI, 0.63-0.91]; P < 0.001) and the Midwest (adjusted odds ratio, 2.15; 95% CI, 1.13-4.07; P = 0.02), South (adjusted odds ratio, 2.71; 95% CI, 1.23-5.99; P = 0.01), and West (adjusted odds ratio, 3.01; 95% CI, 1.21-7.54; P = 0.02) regions as compared with the Northeast. Driving distance was associated with county-level prevalence of diabetes in the univariate model (odds ratio, 1.12; 95% CI, 1.06-1.19; P < 0.001), although it was nonsignificant in the multivariate model. Similar predictors were found for time traveled in minutes. Geographic maldistributions of clinical trial sites exist for diabetic eye disease in the United States. Those with higher travel burden are more likely to reside in a census tract that is rural, low income, and from areas outside the Northeast.
Identifiants
pubmed: 33340769
pii: S2468-6530(20)30487-5
doi: 10.1016/j.oret.2020.12.006
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
879-887Informations de copyright
Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.